PubMed

Evaluation of FibroTest inter-laboratory variations requires standardization on analytical systems and should not be mixed with underpowered histological validation.

Munteanu M, Imbert-Bismut F, Housset C, Messous D, Fellahi S, Poynard T.

Clin Chim Acta. 2009 Nov 23. [Epub ahead of print] No abstract available. PMID: 19931523 [PubMed - as supplied by publisher]

Similarities and differences between REPEAT and EPIC3.

Poynard T, Shiff E.

Ann Intern Med. 2009 Nov 17;151(10):754; author reply 754-5. No abstract available. PMID: 19920277 [PubMed - in process]Related articles

Appropriate evidence-based data overviews demonstrate the diagnostic and prognostic performances of FibroTest in patients with chronic hepatitis C.

Poynard T, Munteanu M, Ngo Y, Ratziu V.

Aliment Pharmacol Ther. 2009 Dec 1;30(11-12):1183-5; author reply 1185-6. No abstract available. PMID: 19888919 [PubMed - in process]Related articles

Long-term efficacy of rosiglitazone in nonalcoholic steatohepatitis: Results of the fatty liver improvement by rosiglitazone therapy (FLIRT 2) extension trial.

Ratziu V, Charlotte F, Bernhardt C, Giral P, Halbron M, Lenaour G, Hartmann-Heurtier A, Bruckert E, Poynard T; LIDO Study Group.

Hepatology. 2009 Sep 9. [Epub ahead of print]PMID: 19877169 [PubMed - as supplied by publisher]Related articles

Aging of the Hepatitis C Virus-Infected Persons in the United States: A Multiple Cohort Model of HCV Prevalence and Disease Progression.

Davis GL, Alter MJ, El-Serag H, Poynard T, Jennings LW.

Gastroenterology. 2009 Oct 24. [Epub ahead of print]PMID: 19861128 [PubMed - as supplied by publisher]Related articles

Evaluation of FibroTest-ActiTest in children with chronic hepatitis C virus infection.

Hermeziu B, Messous D, Fabre M, Munteanu M, Baussan C, Bernard O, Poynard T, Jacquemin E.

Gastroenterol Clin Biol. 2009 Aug 31. [Epub ahead of print]PMID: 19726147 [PubMed - as supplied by publisher]Related articles

Liver fibrosis in viral hepatitis: noninvasive assessment with acoustic radiation force impulse imaging versus transient elastography.

Friedrich-Rust M, Wunder K, Kriener S, Sotoudeh F, Richter S, Bojunga J, Herrmann E, Poynard T, Dietrich CF, Vermehren J, Zeuzem S, Sarrazin C.

Radiology. 2009 Aug;252(2):595-604.PMID: 19703889 [PubMed - indexed for MEDLINE]Related articles

Impact of interferon-alpha treatment on liver fibrosis in patients with chronic hepatitis B: an overview of published trials.

Poynard T, Massard J, Rudler M, Varaud A, Lebray P, Moussalli J, Munteanu M, Ngo Y, Thabut D, Benhamou Y, Ratziu V.

Gastroenterol Clin Biol. 2009 Oct-Nov;33(10-11):916-22. Epub 2009 Jul 28.PMID: 19640664 [PubMed - in process]Related articles

Applicability and variability of liver stiffness measurements according to probe position.

Ingiliz P, Chhay KP, Munteanu M, Lebray P, Ngo Y, Roulot D, Benhamou Y, Thabut D, Ratziu V, Poynard T.

World J Gastroenterol. 2009 Jul 21;15(27):3398-404.PMID: 19610141 [PubMed - indexed for MEDLINE]Related articlesFree article

Natural variability of NS3 protease in patients infected with genotype 4 hepatitis C virus (HCV): implications for antiviral treatment using specifically targeted antiviral therapy for HCV.

Akhavan S, Schnuriger A, Lebray P, Benhamou Y, Poynard T, Thibault V.

J Infect Dis. 2009 Aug 15;200(4):524-7.PMID: 19604114 [PubMed - indexed for MEDLINE]Related articles

Assessment of Liver Fibrosis and Steatosis in PBC With FibroScan, MRI, MR-spectroscopy, and Serum Markers.

Friedrich-Rust M, Müller C, Winckler A, Kriener S, Herrmann E, Holtmeier J, Poynard T, Vogl TJ, Zeuzem S, Hammerstingl R, Sarrazin C.

J Clin Gastroenterol. 2009 Jul 2. [Epub ahead of print]PMID: 19581812 [PubMed - as supplied by publisher]Related articles

Assessment of liver fibrosis: noninvasive means.

Poynard T, Morra R, Ingiliz P, Imbert-Bismut F, Thabut D, Messous D, Munteanu M, Massard J, Benhamou Y, Ratziu V.

Saudi J Gastroenterol. 2008 Oct;14(4):163-73.PMID: 19568532 [PubMed - in process]Related articlesFree article

[Nonalcoholic fatty liver disease: 30 years research changed NASH]

Ratziu V, Poynard T.

Gastroenterol Clin Biol. 2009 Aug-Sep;33(8-9):850-8. Epub 2009 Jun 21. French. PMID: 19540686 [PubMed - in process]Related articles

Liver biopsy: the best standard...when everything else fails.

Poynard T, Benhamou Y, Thabut D, Ratziu V.

J Hepatol. 2009 Jun;50(6):1267-8. Epub 2009 Mar 12. No abstract available. PMID: 19380171 [PubMed - indexed for MEDLINE]Related articles

The risks of changing the rules for previously validated biomarkers and using the same patients several times. Response letter to Calès et al. Gastroenterol Clin Biol 2008;32:1050-60: "Evaluation and improvement of a reliable diagnosis of cirrhosis by blood tests".

Munteanu M, Ngo Y, Ratziu V, Poynard T.

Gastroenterol Clin Biol. 2009 May;33(5):387-8; author reply 388-9. Epub 2009 Apr 15. No abstract available. PMID: 19372019 [PubMed - in process]Related articles

Baseline characteristics and early on-treatment response predict the outcomes of 2 years of telbivudine treatment of chronic hepatitis B.

Zeuzem S, Gane E, Liaw YF, Lim SG, DiBisceglie A, Buti M, Chutaputti A, Rasenack J, Hou J, O'Brien C, Nguyen TT, Jia J, Poynard T, Belanger B, Bao W, Naoumov NV.

J Hepatol. 2009 Jul;51(1):11-20. Epub 2009 Feb 12.PMID: 19345439 [PubMed - indexed for MEDLINE]Related articles

Prolonged therapy for hepatitis C with low-dose peginterferon.

Poynard T, Ratziu V.

N Engl J Med. 2009 Mar 12;360(11):1152; author reply 1152-3. No abstract available. PMID: 19283890 [PubMed - indexed for MEDLINE]Related articles

Peginterferon alfa-2b and ribavirin: effective in patients with hepatitis C who failed interferon alfa/ribavirin therapy.

Poynard T, Colombo M, Bruix J, Schiff E, Terg R, Flamm S, Moreno-Otero R, Carrilho F, Schmidt W, Berg T, McGarrity T, Heathcote EJ, Gonçales F, Diago M, Craxi A, Silva M, Bedossa P, Mukhopadhyay P, Griffel L, Burroughs M, Brass C, Albrecht J; Epic Study Group.

Gastroenterology. 2009 May;136(5):1618-28.e2. Epub 2009 Jan 22.PMID: 19208349 [PubMed - indexed for MEDLINE]Related articles

Discordance between results of biomarkers of fibrosis shows that it is at least a "ménage à deux".

Munteanu M, Lebray P, Massard J, Moussalli J, Varaut A, Ngo Y, Thabut D, Imbert-Bismut F, Benhamou Y, Ratziu V, Poynard T.

Gastroenterol Clin Biol. 2009 Feb;33(2):133-4. Epub 2009 Feb 3. No abstract available. PMID: 19193507 [PubMed - in process]Related articles

Immediate listing for liver transplantation versus standard care for Child-Pugh stage B alcoholic cirrhosis: a randomized trial.

Vanlemmens C, Di Martino V, Milan C, Messner M, Minello A, Duvoux C, Poynard T, Perarnau JM, Piquet MA, Pageaux GP, Dharancy S, Silvain C, Hillaire S, Thiefin G, Vinel JP, Hillon P, Collin E, Mantion G, Miguet JP; TRANSCIAL Study Group.

Ann Intern Med. 2009 Feb 3;150(3):153-61.PMID: 19189904 [PubMed - indexed for MEDLINE]Related articlesFree article

Impact of adefovir dipivoxil on liver fibrosis and activity assessed with biochemical markers (FibroTest-ActiTest) in patients infected by hepatitis B virus.

Poynard T, Ngo Y, Marcellin P, Hadziyannis S, Ratziu V, Benhamou Y; Adefovir Dipivoxil 437 and 438 Study Groups.

J Viral Hepat. 2009 Mar;16(3):203-13. Epub 2008 Oct 22.PMID: 19175871 [PubMed - indexed for MEDLINE]Related articles

Liver damage underlying unexplained transaminase elevation in human immunodeficiency virus-1 mono-infected patients on antiretroviral therapy.

Ingiliz P, Valantin MA, Duvivier C, Medja F, Dominguez S, Charlotte F, Tubiana R, Poynard T, Katlama C, Lombès A, Benhamou Y.

Hepatology. 2009 Feb;49(2):436-42.PMID: 19085967 [PubMed - indexed for MEDLINE]Related articles

FibroTest-ActiTest as a non-invasive marker of liver fibrosis.

Halfon P, Munteanu M, Poynard T.

Gastroenterol Clin Biol. 2008 Sep;32(6 Suppl 1):22-39.PMID: 18973844 [PubMed - indexed for MEDLINE]Related articlesFree article

Methodological aspects of the interpretation of non-invasive biomarkers of liver fibrosis: a 2008 update.

Poynard T, Muntenau M, Morra R, Ngo Y, Imbert-Bismut F, Thabut D, Messous D, Massard J, Lebray P, Moussalli J, Benhamou Y, Ratziu V.

Gastroenterol Clin Biol. 2008 Sep;32(6 Suppl 1):8-21. Review.PMID: 18973843 [PubMed - indexed for MEDLINE]Related articlesFree article

Diagnostic and prognostic values of noninvasive biomarkers of fibrosis in patients with alcoholic liver disease.

Naveau S, Gaudé G, Asnacios A, Agostini H, Abella A, Barri-Ova N, Dauvois B, Prévot S, Ngo Y, Munteanu M, Balian A, Njiké-Nakseu M, Perlemuter G, Poynard T.

Hepatology. 2009 Jan;49(1):97-105.PMID: 19053048 [PubMed - indexed for MEDLINE]Related articles

Concordance in a world without a gold standard: a new non-invasive methodology for improving accuracy of fibrosis markers.

Poynard T, Ingiliz P, Elkrief L, Munteanu M, Lebray P, Morra R, Messous D, Bismut FI, Roulot D, Benhamou Y, Thabut D, Ratziu V.

PLoS One. 2008;3(12):e3857. Epub 2008 Dec 4.PMID: 19052646 [PubMed - indexed for MEDLINE]Related articlesFree article

Efficacy and safety of adefovir dipivoxil plus pegylated interferon-alpha2a for the treatment of lamivudine-resistant hepatitis B virus infection in HIV-infected patients.

Ingiliz P, Valantin MA, Thibault V, Duvivier C, Dominguez S, Katlama C, Poynard T, Benhamou Y.

Antivir Ther. 2008;13(7):895-900.PMID: 19043923 [PubMed - indexed for MEDLINE]Related articles

The diagnostic value of combining carbohydrate-deficient transferrin, fibrosis, and steatosis biomarkers for the prediction of excessive alcohol consumption.

Imbert-Bismut F, Naveau S, Morra R, Munteanu M, Ratziu V, Abella A, Messous D, Thabut D, Benhamou Y, Poynard T.

Eur J Gastroenterol Hepatol. 2009 Jan;21(1):18-27.PMID: 19011575 [PubMed - indexed for MEDLINE]Related articles

Biomarkers of liver fibrosis.

Poynard T, Morra R, Ingiliz P, Imbert-Bismut F, Thabut D, Messous D, Munteanu M, Massard J, Benhamou Y, Ratziu V.

Adv Clin Chem. 2008;46:131-60. Review.PMID: 19004189 [PubMed - indexed for MEDLINE]Related articles

Liver stiffness is an unreliable marker of liver fibrosis in patients with cardiac insufficiency.

Lebray P, Varnous S, Charlotte F, Varaut A, Poynard T, Ratziu V.

Hepatology. 2008 Dec;48(6):2089. No abstract available. PMID: 19003902 [PubMed - indexed for MEDLINE]Related articles

[Adherence to pegylated combination therapy in patients with chronic hepatitis C. Importance of the hepatologist, general practitioner, and nurse]

Wartelle-Bladou C, Rosenthal E, Ratziu V, De Lédinghen V, Lang JP, Poynard T.

Gastroenterol Clin Biol. 2008 Mar;32(3 Pt 2):S96-S108. Review. French. PMID: 18675187 [PubMed - indexed for MEDLINE]Related articles

[Non-invasive evaluation of liver fibrosis in hepatitis C]

de Lédinghen V, Poynard T, Wartelle C, Rosenthal E.

Gastroenterol Clin Biol. 2008 Mar;32(3 Pt 2):S90-5. Review. French. PMID: 18675186 [PubMed - indexed for MEDLINE]Related articles

An accurate definition of the status of inactive hepatitis B virus carrier by a combination of biomarkers (FibroTest-ActiTest) and viral load.

Ngo Y, Benhamou Y, Thibault V, Ingiliz P, Munteanu M, Lebray P, Thabut D, Morra R, Messous D, Charlotte F, Imbert-Bismut F, Bonnefont-Rousselot D, Moussalli J, Ratziu V, Poynard T.

PLoS One. 2008 Jul 2;3(7):e2573. Erratum in: PLoS ONE. 2008;3(7). doi: 10.1371/annotation/9f8332b9-fdc0-48e8-967b-3c504024b9d1. Rousselot-Bonnefont, Dominique [corrected to Bonnefont-Rousselot, Dominique]. PMID: 18596917 [PubMed - indexed for MEDLINE]Related articlesFree article

Noninvasive biomarkers for the screening of fibrosis, steatosis and steatohepatitis in patients with metabolic risk factors: FibroTest-FibroMax experience.

Munteanu M, Ratziu V, Morra R, Messous D, Imbert-Bismut F, Poynard T.

J Gastrointestin Liver Dis. 2008 Jun;17(2):187-91. Review. No abstract available. PMID: 18568141 [PubMed - indexed for MEDLINE]Related articlesFree article

Screening for liver fibrosis by using a noninvasive biomarker in patients with diabetes.

Jacqueminet S, Lebray P, Morra R, Munteanu M, Devers L, Messous D, Bernard M, Hartemann-Heurtier A, Imbert-Bismut F, Ratziu V, Grimaldi A, Poynard T.

Clin Gastroenterol Hepatol. 2008 Jul;6(7):828-31. Epub 2008 Jun 4.PMID: 18524692 [PubMed - indexed for MEDLINE]Related articles

Rosiglitazone for nonalcoholic steatohepatitis: one-year results of the randomized placebo-controlled Fatty Liver Improvement with Rosiglitazone Therapy (FLIRT) Trial.

Ratziu V, Giral P, Jacqueminet S, Charlotte F, Hartemann-Heurtier A, Serfaty L, Podevin P, Lacorte JM, Bernhardt C, Bruckert E, Grimaldi A, Poynard T; LIDO Study Group.

Gastroenterology. 2008 Jul;135(1):100-10. Epub 2008 Apr 8.PMID: 18503774 [PubMed - indexed for MEDLINE]Related articles

Reproducibility of non-invasive fibrosis biomarkers, FibroMeter and FibroTest, could be improved by respecting the analytical standardizations.

Munteanu M, Imbert-Bismut F, Messous D, Morra R, Thabut D, Lebray P, Benhamou Y, Ratziu V, Poynard T.

Clin Biochem. 2008 Sep;41(13):1113-4. Epub 2008 May 3. No abstract available. PMID: 18486610 [PubMed - indexed for MEDLINE]Related articles

Gemcitabine plus oxaliplatin (GEMOX) combined with cetuximab in patients with progressive advanced stage hepatocellular carcinoma: results of a multicenter phase 2 study.

Asnacios A, Fartoux L, Romano O, Tesmoingt C, Louafi S S, Mansoubakht T, Artru P, Poynard T, Rosmorduc O, Hebbar M, Taieb J.

Cancer. 2008 Jun 15;112(12):2733-9.PMID: 18412149 [PubMed - indexed for MEDLINE]Related articlesFree article

FibroTest is effective in patients with normal transaminases, when accuracy is standardized on fibrosis stage prevalence.

Poynard T, Munteanu M, Ngo Y, Moussalli J, Lebray P, Thabut D, Benhamou Y, Ratziu V.

J Viral Hepat. 2008 Jun;15(6):472-3; author reply 474. Epub 2008 Mar 24. No abstract available. PMID: 18363670 [PubMed - indexed for MEDLINE]Related articles

Noninvasive assessment of liver fibrosis in patients with Fontan circulation using transient elastography and biochemical fibrosis markers.

Friedrich-Rust M, Koch C, Rentzsch A, Sarrazin C, Schwarz P, Herrmann E, Lindinger A, Sarrazin U, Poynard T, Schäfers HJ, Zeuzem S, Abdul-Khaliq H.

J Thorac Cardiovasc Surg. 2008 Mar;135(3):560-7.PMID: 18329470 [PubMed - indexed for MEDLINE]Related articles

Optimal correlation between different instruments for Fibrotest-Actitest protein measurement in patients with chronic hepatitis C.

Rosenthal-Allieri MA, Tran A, Halfon P, Imbert-Bismut F, Munteanu M, Messous D, Peritore ML, Poynard T, Bernard A.

Gastroenterol Clin Biol. 2007 Oct;31(10):815-21.PMID: 18166859 [PubMed - indexed for MEDLINE]Related articlesFree article

FibroTest has better diagnostic and prognostic values than the aspartate aminotransferase-to-platelet ratio index in patients with chronic hepatitis C.

Morra R, Lebray P, Ingiliz P, Ngo Y, Munteanu M, Ratziu V, Poynard T.

Hepatology. 2008 Jan;47(1):353-4; author reply 354-6. No abstract available. PMID: 18161711 [PubMed - indexed for MEDLINE]Related articles

Nodular regenerative hyperplasia: the main liver disease in patients with primary hypogammaglobulinemia and hepatic abnormalities.

Malamut G, Ziol M, Suarez F, Beaugrand M, Viallard JF, Lascaux AS, Verkarre V, Bechade D, Poynard T, Hermine O, Cellier C.

J Hepatol. 2008 Jan;48(1):74-82. Epub 2007 Oct 17.PMID: 17998147 [PubMed - indexed for MEDLINE]Related articles

Model for end-stage liver disease score and systemic inflammatory response are major prognostic factors in patients with cirrhosis and acute functional renal failure.

Thabut D, Massard J, Gangloff A, Carbonell N, Francoz C, Nguyen-Khac E, Duhamel C, Lebrec D, Poynard T, Moreau R.

Hepatology. 2007 Dec;46(6):1872-82.PMID: 17972337 [PubMed - indexed for MEDLINE]Related articles

[Non invasive markers using for the assessment of fibrosis in hepatitis C]

Zarski JP, Bedossa P, Bronowicki JP, Doffoel M, Poynard T.

Gastroenterol Clin Biol. 2007 Aug-Sep;31(8-9 Pt 3):4S34-9. Review. French. PMID: 17965633 [PubMed - indexed for MEDLINE]Related articles

Meta-analyses of FibroTest diagnostic value in chronic liver disease.

Poynard T, Morra R, Halfon P, Castera L, Ratziu V, Imbert-Bismut F, Naveau S, Thabut D, Lebrec D, Zoulim F, Bourliere M, Cacoub P, Messous D, Munteanu M, de Ledinghen V.

BMC Gastroenterol. 2007 Oct 15;7:40.PMID: 17937811 [PubMed - indexed for MEDLINE]Related articlesFree article

High-density lipoprotein administration attenuates liver proinflammatory response, restores liver endothelial nitric oxide synthase activity, and lowers portal pressure in cirrhotic rats.

Thabut D, Tazi KA, Bonnefont-Rousselot D, Aller M, Farges O, Guimont MC, Tellier Z, Guichard C, Ogier-Denis E, Poynard T, Moreau R, Lebrec D.

Hepatology. 2007 Dec;46(6):1893-906.PMID: 17918268 [PubMed - indexed for MEDLINE]Related articles

FibroMAX: towards a new universal biomarker of liver disease?

Morra R, Munteanu M, Imbert-Bismut F, Messous D, Ratziu V, Poynard T.

Expert Rev Mol Diagn. 2007 Sep;7(5):481-90. Review.PMID: 17892356 [PubMed - indexed for MEDLINE]Related articles

Diagnostic value of serum protein profiling by SELDI-TOF ProteinChip compared with a biochemical marker, FibroTest, for the diagnosis of advanced fibrosis in patients with chronic hepatitis C.

Morra R, Munteanu M, Bedossa P, Dargere D, Janneau JL, Paradis V, Ratziu V, Charlotte F, Thibault V, Imbert-Bismut F, Poynard T.

Aliment Pharmacol Ther. 2007 Sep 15;26(6):847-58.PMID: 17767469 [PubMed - indexed for MEDLINE]Related articlesFree article

Histological progression of non-alcoholic fatty liver disease: a critical reassessment based on liver sampling variability.

Ratziu V, Bugianesi E, Dixon J, Fassio E, Ekstedt M, Charlotte F, Kechagias S, Poynard T, Olsson R.

Aliment Pharmacol Ther. 2007 Sep 15;26(6):821-30.PMID: 17767466 [PubMed - indexed for MEDLINE]Related articlesFree article